NCT02828774View on ClinicalTrials.gov

Peptide-drug-conjugates for Personalized, Targeted Therapy of Chronic Lymphocytic Leukemia

UnknownOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2020

Conditions
CLL
Interventions
OTHER

there will be no intervention.

this study is observational, procedure are done in vitro and on animal models.

Sponsors
All Listed Sponsors
lead

Assuta Medical Center

OTHER

NCT02828774 - Peptide-drug-conjugates for Personalized, Targeted Therapy of Chronic Lymphocytic Leukemia | Biotech Hunter | Biotech Hunter